Showing results (551-560 of 667) with videos related to

Sort By:
Pageof 67
Cancer Cell|November 11, 2022
Challenges in neoantigen-directed therapeuticsLien Lybaert, Steve Lefever, Bruno Fant, et al.
Plos One|January 6, 2011
A phase II trial of sorafenib in metastatic melanoma with tissue correlatesPatrick A Ott, Anne Hamilton, Christina Min, et al.
Oncology|June 12, 2017
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of CareChloe Goldman, Jeremy Tchack, Eric M Robinson, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation TherapyAndrew Bang, Tyler J Wilhite, Luke R G Pike, et al.
Immunogenetics|April 21, 2023
Evolution of immunogenetic components encoding ultralong CDR H3Jeannine A Ott, Christian Mitchell, Morgan Sheppard, et al.
Neurology|March 24, 2004
Effect of smoking on global cognitive function in nondemented elderlyA Ott, K Andersen, M E Dewey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2017
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 TrialJean-Sebastien Frenel, Christophe Le Tourneau, Bert O'Neil, et al.
Investigational New Drugs|August 7, 2012
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanomaPatrick A Ott, Richard D Carvajal, Neeta Pandit-Taskar, et al.
Alimentary Pharmacology & Therapeutics|May 11, 2005
Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trialE A Ott, L E Mazzoleni, M I Edelweiss, et al.
Journal for Immunotherapy of Cancer|November 9, 2019
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanomaMarieke J Krimphove, Karl H Tully, David F Friedlander, et al.
Pageof 67